Table 3.

The OR of the J-HAQ score progression by logistic regression model in patients fulfilling various remission criteria over 2.5 years. Values are OR (95% CI).

NBoolean TrialSDAIBoolean PracticeCDAIDAS28
0
10.54 (0.33–0.87)0.98 (0.54–1.81)0.59 (0.36–0.97)0.92 (0.51–1.64)
20.55 (0.33–0.92)0.58 (0.32–1.06)0.51 (0.31–0.86)0.44 (0.24–0.80)0.58 (0.28–1.17)
30.48 (0.28–0.82)0.39 (0.21–0.73)0.50 (0.29–0.86)0.42 (0.24–0.75)0.48 (0.26–0.91)
40.29 (0.16–0.51)0.56 (0.31–1.01)0.40 (0.23–0.70)0.50 (0.28–0.90)0.46 (0.25–0.85)
50.24 (0.13–0.47)0.36 (0.20–0.68)0.29 (0.16–0.54)0.38 (0.21–0.70)0.23 (0.12–0.44)
60.07 (0.03–0.15)0.10 (0.05–0.20)0.07 (0.03–0.14)0.07 (0.04–0.15)0.15 (0.08–0.29)
  • J-HAQ: Japanese version of the Health Assessment Questionnaire; N: no. data collections in which patients achieved remission criteria; SDAI: Simplified Disease Activity Index; CDAI: Clinical Disease Activity Index; DAS28: 28-joint Disease Activity Score.